The U.S. vaccine industry is experiencing robust growth propelled by advancements in biotechnology and rising prevalence of infectious diseases. This sector’s strategic importance in public health has intensified, reflected in heightened investments ...

Markdown supported · ⌘↵ to post
No responses yet.